Academic Journals Database
Disseminating quality controlled scientific knowledge

Soft Tissue Recurrence Of Giant Cell Tumour

ADD TO MY LIST
 
Author(s): Krishnakumar R*

Journal: Journal of Orthopaedics
ISSN 0972-978X

Volume: 4;
Issue: 4;
Date: 2007;
Original page

Keywords: Giant Cell Tumour | Soft Tissue Recurrence

ABSTRACT
Cooper and Travers first described giant cell tumor of bone in 1818 (4). Bloodgood coined he term giant-cell tumor in 1912(1). In 1940 Jaffe et al distinguished giant-cell tumor as a distinct clinical, radiographic, and pathological entity that is separate from other lesions containing giant cells(8). Giant cell tumor of bone is characterized radiographically by a well delineated, eccentric, purely lytic, epiphyseal lesion with the absence of reactive sclerosis and periosteal new bone formation abutting the articular surface. Giant cell tumor of the bone accounts for 4-5% of primary bone tumors and 18.2% of benign bone tumors. The incidence is increased in patients with Paget disease of the bone, in which giant cell tumor is a rare neoplastic complication. Typically, giant cell tumors occur in skeletally mature patients aged 20-40 years. The incidence peaks in those aged 20-30 years. Although intraosseous recurrence of giant cell tumour is a well recognized complication; soft tissue recurrences are rarely encountered
Save time & money - Smart Internet Solutions      Why do you need a reservation system?